Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

Mar 14, 2016

30339_dirs_2016-03-14_c984cc8e-94f0-4ff2-bafa-5c05e4d40873.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-23 Common Stock A 3212.0000 $59.6400 Acquired 30707.0285 Direct

Footnotes

F1: Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12. Original filing did not include 41 shares that were erroneously withheld for taxes. New number represents correct amount received.